Tango Therapeutics (TNGX) EBT (2020 - 2025)
Historic EBT for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $15.9 million.
- Tango Therapeutics' EBT rose 15452.55% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.4 million, marking a year-over-year increase of 1849.35%. This contributed to the annual value of -$130.1 million for FY2024, which is 2803.27% down from last year.
- Tango Therapeutics' EBT amounted to $15.9 million in Q3 2025, which was up 15452.55% from -$38.8 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' EBT ranged from a high of $15.9 million in Q3 2025 and a low of -$39.8 million during Q1 2025
- In the last 5 years, Tango Therapeutics' EBT had a median value of -$25.5 million in 2024 and averaged -$24.2 million.
- Its EBT has fluctuated over the past 5 years, first plummeted by 95625593.22% in 2021, then surged by 15452.55% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' EBT stood at -$21.9 million in 2021, then tumbled by 32.65% to -$29.0 million in 2022, then fell by 5.88% to -$30.7 million in 2023, then fell by 22.48% to -$37.6 million in 2024, then skyrocketed by 142.19% to $15.9 million in 2025.
- Its EBT was $15.9 million in Q3 2025, compared to -$38.8 million in Q2 2025 and -$39.8 million in Q1 2025.